These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9021404)

  • 41. Signal transduction by human NK cell MHC-recognizing receptors.
    Binstadt BA; Brumbaugh KM; Leibson PJ
    Immunol Rev; 1997 Feb; 155():197-203. PubMed ID: 9059895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural killer cells fertile with receptors for HLA-G?
    Lanier LL
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5343-5. PubMed ID: 10318882
    [No Abstract]   [Full Text] [Related]  

  • 43. HLA class-I-specific NK receptors belong to two distinct molecular families and display inhibitory or activating function.
    Cantoni C; Biassoni R
    Res Immunol; 1997; 148(3):146-50. PubMed ID: 9255864
    [No Abstract]   [Full Text] [Related]  

  • 44. HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation.
    Duygu B; Olieslagers TI; Groeneweg M; Voorter CEM; Wieten L
    Front Immunol; 2021; 12():680480. PubMed ID: 34295330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Soluble HLA class I/CD8 ligation triggers apoptosis in EBV-specific CD8+ cytotoxic T lymphocytes by Fas/Fas-ligand interaction.
    Contini P; Ghio M; Merlo A; Brenci S; Filaci G; Indiveri F; Puppo F
    Hum Immunol; 2000 Dec; 61(12):1347-51. PubMed ID: 11163092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs.
    Bléry M; Delon J; Trautmann A; Cambiaggi A; Olcese L; Biassoni R; Moretta L; Chavrier P; Moretta A; Daëron M; Vivier E
    J Biol Chem; 1997 Apr; 272(14):8989-96. PubMed ID: 9083022
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes.
    Moretta A; Biassoni R; Bottino C; Pende D; Vitale M; Poggi A; Mingari MC; Moretta L
    Immunol Rev; 1997 Feb; 155():105-17. PubMed ID: 9059886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HLA-class I-specific inhibitory receptors in HIV-1 infection.
    De Maria A; Moretta L
    Hum Immunol; 2000 Jan; 61(1):74-81. PubMed ID: 10658980
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors.
    Valés-Gómez M; Reyburn HT; Mandelboim M; Strominger JL
    Immunity; 1998 Sep; 9(3):337-44. PubMed ID: 9768753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular structures of HLA-specific human NK cell receptors.
    Cantoni C; Verdiani S; Falco M; Conte R; Biassoni R
    Chem Immunol; 1996; 64():88-103. PubMed ID: 8942074
    [No Abstract]   [Full Text] [Related]  

  • 51. Natural killer cell receptors and MHC class I interactions.
    Lanier LL
    Curr Opin Immunol; 1997 Feb; 9(1):126-31. PubMed ID: 9039769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NK cells: a lesson from mismatched hematopoietic transplantation.
    Frohn C; Brand JM; Luhm J
    Trends Immunol; 2003 Jan; 24(1):8-9; author reply 9-10. PubMed ID: 12495715
    [No Abstract]   [Full Text] [Related]  

  • 53. Natural killer receptor repertoires in transplantation.
    Jones DC; Young NT
    Eur J Immunogenet; 2003 Jun; 30(3):169-76. PubMed ID: 12786992
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allogeneic MHC class I ligands and their role in positive and negative regulation of human cytotoxic effector cells.
    Falk CS; Schendel DJ
    Hum Immunol; 2002 Jan; 63(1):8-19. PubMed ID: 11916173
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crystallization and preliminary X-ray analysis of the low-affinity complex between human leukocyte antigen-G (HLA-G) and leukocyte Ig-like receptor B2 (LILRB2).
    Shiroishi M; Maenaka K
    Protein Pept Lett; 2009; 16(4):447-9. PubMed ID: 19356145
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crystallization and preliminary diffraction studies of the extracellular region of human p58 killer cell inhibitory receptor (KIR2).
    Maenaka K; Juji T; Tadokoro K; Harlos K; Stuart DI; Jones EY
    Acta Crystallogr D Biol Crystallogr; 1998 May; 54(Pt 3):433-5. PubMed ID: 9761919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunoglobulin superfamily inhibitory receptors: from natural killer cells to antigen-presenting cells.
    Colonna M
    Res Immunol; 1997; 148(3):169-71. PubMed ID: 9255869
    [No Abstract]   [Full Text] [Related]  

  • 58. HLA reduction of human T cells facilitates generation of immunologically multicompatible cellular products.
    Winterhalter PM; Warmuth L; Hilgendorf P; Schütz JM; Dötsch S; Tonn T; Cicin-Sain L; Busch DH; Schober K
    Blood Adv; 2024 Jul; 8(13):3416-3426. PubMed ID: 38640254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Does HLA-G prevent tissue destruction in psoriasis?
    Sweeney C; Kirby B
    Br J Dermatol; 2011 May; 164(5):1118-9. PubMed ID: 21250964
    [No Abstract]   [Full Text] [Related]  

  • 60. Silencing of HLA class I on primary human hepatocytes as a novel strategy for reduction in alloreactivity.
    Figueiredo C; Oldhafer F; Wittauer EM; Carvalho-Oliveira M; Akhdar A; Beetz O; Chen-Wacker C; Yuzefovych Y; Falk CS; Blasczyk R; Vondran FWR
    J Cell Mol Med; 2019 Aug; 23(8):5705-5714. PubMed ID: 31180181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.